PTC Therapeutics, Inc. (BH3.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
As of 08:05AM CEST. Market open.
| Previous close | 31.40 |
| Open | 31.00 |
| Bid | 30.20 x N/A |
| Ask | 31.60 x N/A |
| Day's range | 31.00 - 31.00 |
| 52-week range | 16.40 - 54.50 |
| Volume | |
| Avg. volume | 0 |
| Market cap | 2.378B |
| Beta (5Y monthly) | 0.67 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -7.17 |
| Earnings date | 01 Aug 2024 - 05 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
PR NewswirePTC Therapeutics to Participate at Upcoming Investor Conferences
PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the company will present a company overview at the following conferences:
Investor's Business DailyPTC Therapeutics Stock Sees IBD RS Rating Climb To 72
PTC Therapeutics shows improving price performance, earning an upgrade to its IBD Relative Strength Rating
Insider MonkeyPTC Therapeutics, Inc. (NASDAQ:PTCT) Q1 2024 Earnings Call Transcript
PTC Therapeutics, Inc. (NASDAQ:PTCT) Q1 2024 Earnings Call Transcript April 25, 2024 PTC Therapeutics, Inc. beats earnings expectations. Reported EPS is $-1.2, expectations were $-1.31. PTC Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day and thank […]
© 2024 Yahoo. All rights reserved.